Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
 [1]
Current Assets:    
Cash and cash equivalents $ 28,458 $ 50,612
Restricted cash 3,955 11,513
Accounts receivable, net (net of allowance for doubtful accounts of $135 and $378, respectively) 76,455 86,888
Inventories 61,088 54,373
Derivative instruments 7,384 15,839
Notes receivable, current 3,125
Other current assets 8,966 7,176
Total current assets 186,306 229,526
Property and equipment, net 233,475 222,550
Other Assets:    
Right of use operating lease assets, net 12,895 13,413
Notes receivable, noncurrent 11,641
Intangible assets, net 9,234 2,678
Goodwill 5,970
Other assets 6,788 5,145
Total other assets 34,887 32,877
Total Assets 454,668 484,953
Current Liabilities:    
Accounts payable – trade 17,493 23,251
Accrued liabilities 22,172 21,307
Current portion – operating leases 3,646 3,909
Derivative instruments 1,106 13,582
Other current liabilities 10,096 7,553
Total current liabilities 54,513 69,602
Long-term debt, net of current portion 45,888 50,361
Operating leases, net of current portion 9,201 9,382
Other liabilities 10,068 10,394
Total Liabilities 119,670 139,739
Commitments and Contingencies (Note 7)
Alto Ingredients, Inc. Stockholders’ Equity:    
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of September 30, 2022 and December 31, 2021; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of September 30, 2022 and December 31, 2021; liquidation preference of $18,075 as of September 30, 2022 1 1
Common stock, $0.001 par value; 300,000 shares authorized; 73,956 and 72,778 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 74 73
Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of September 30, 2022 and December 31, 2021, respectively
Additional paid-in capital 1,036,459 1,037,205
Accumulated other comprehensive loss (284) (284)
Accumulated deficit (701,252) (691,781)
Total Stockholders’ Equity 334,998 345,214
Total Liabilities and Stockholders’ Equity $ 454,668 $ 484,953
[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2021.